Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Parenteral thiamine dose-ranging study for Wernicke-Korsakoff syndrome
ACTRN12614000327684Phase 4Recruiting
- Sponsor
- Dr Kylie Dingwall
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of thiamine in Wernicke-Korsakoff syndrome (WKS) and thiamine deficiency (6 arms), sponsored by Dr Kylie Dingwall. Primary endpoints: Cognitive outcomes and Neurological outcomes. Started Sep 2014; status: recruiting.
02
Drugs
thiamine
03
Conditions
Wernicke-Korsakoff syndrome (WKS)thiamine deficiency
Beyond the preview
Go deeper on ACTRN12614000327684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000327684.